This week in aesthetics, we announce our fall issue, Innovative Perspectives, highlight botulinum toxin A for upper lip enhancement, and more.
This week in aesthetics, Will Kirby, DO, FAOCD, talks with Todd Tillemans, chief executive officer of Cynosure, in his monthly column, Crown Laboratories announces the acquisition of StriVectin, Joel Cohen, MD, talks botulinum toxin A for upper lip enhancement, Randolph Waldman, MD, discusses the Delta and Lambda variants in his latest editorial, Michael H. Gold, MD, examines game-changers in hair loss treatment, and we announce our fall issue, Innovative Perspectives.
In this month’s “Meet the Aesthetic Expert” column, Will Kirby, DO, FAOCD, talks with Todd Tillemans, chief executive officer of Cynosure, about his journey from Marine to the aesthetics industry, investing in technology, and improving patient accessibility.
Crown Laboratories and L Catterton announce they will acquire StriVectin to create Crown Premium Skincare.
A recent study finds BTA an effective alternative to fillers, but it should be used with caution.
In his latest editorial, Randolph Waldman, MD, discusses the Delta and Lambda variants of COVID-19, complex questions about vaccinations, and what boosters mean for the pandemic’s future.
More options are available to address alopecia, but not all are backed by equally solid science. Strategies for choosing and using new treatments and procedures for full-cycle hair loss management were highlighted at the Music City Symposium for Cosmetic Advances & Laser Education 16th Annual Meeting.
In this Fall issue, Jack Zamora, MD, highlights stem cells for wound healing, Alan J. Bauman, MD, ABHRS, FISHRS, and Jessica A. Shepherd, MD, MBA, FACOG, discuss why physicians shouldn’t shrug off postpartum hair loss, and aesthetic physicians highlight the power of dermatology TikTok.